Breaking News Instant updates and real-time market news.

AMGN

Amgen

$182.24

-3.76 (-2.02%)

16:05
07/08/19
07/08
16:05
07/08/19
16:05

Amgen completes offer to Nuevolution shareholders

Amgen announced a recommended public cash offer to the shareholders of Nuevolution AB to tender all their shares in Nuevolution to Amgen for SEK 32.50 per share in cash. At the end of the Offer acceptance period on July 4, the Offer had been accepted by shareholders representing a total of 48,313,224 shares and votes in Nuevolution, corresponding to approximately 97.6% of the total number of issued and outstanding shares and votes in Nuevolution. As communicated in the Offer announcement and the offer document describing the Offer, which was published on June 12, the Offer did not include warrants issued by Nuevolution to participants under the incentive programs implemented by Nuevolution, and Amgen provided Warrant holders an opportunity to sell all their Warrants to Amgen outside of the Offer. The Warrant Offer has been accepted by Warrant holders representing all 5,109,254 Warrants allotted under the programs, corresponding to 5,109,254 shares and votes in Nuevolution, if exercised. In total, the securities tendered by shareholders and Warrant holders into the Offer and the Warrant Offer, respectively, correspond to approximately 97.8% of the total number of shares and votes in Nuevolution on a fully diluted basis. Amgen did not own or control any securities in Nuevolution at the time of the Offer announcement, and has not, since then, acquired any securities in Nuevolution outside of the Offer and the Warrant Offer. Amgen hereby declares the Offer unconditional, announces that all conditions for completion of the Offer have either been satisfied or waived and declares that it is completing the Offer. Settlement in respect of shares duly tendered on or before July 4 is expected to occur on or around July 15. To give remaining shareholders of Nuevolution the possibility to accept the Offer, Amgen has decided to extend the acceptance period until 17:00 (CEST) on July 24. Settlement in respect of shares tendered during the extended acceptance period is expected to occur on or around July 19 for shareholders accepting the Offer no later than on July 12 and on or around July 31 for the shareholders accepting the Offer after July 12. During the extended acceptance period, Amgen may acquire, or enter into agreements to acquire, shares in Nuevolution outside of the Offer. Such acquisitions or agreements will be made in accordance with applicable Swedish laws and regulations. Amgen intends to initiate compulsory acquisition proceedings with respect to the remaining Nuevolution shares, and to promote a de-listing of the Nuevolution shares from Nasdaq Stockholm.

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

AMGN Amgen
$182.24

-3.76 (-2.02%)

06/07/19
GUGG
06/07/19
DOWNGRADE
GUGG
Neutral
Guggenheim downgrades Mirati to Neutral following near-tripling of stock
As previously reported, Guggenheim analyst Michael Schmidt downgraded Mirati Therapeutics (MRTX) to Neutral from Buy, noting that the shares have nearly tripled since data were presented at the European Society for Medical Oncology, or ESMO, meeting in October. While Schmidt said Amgen's (AMGN) KRAS inhibitor Phase I data presented at the American Society of Clinical Oncology meeting validates MRTX849's potential mechanism of action, he sees a "lot of upside" priced in at the current valuation despite the remaining development risks. He also believes investor expectations have significantly increased ahead of Mirati's own Phase I data presentation in the second half of the year.
06/05/19
HCWC
06/05/19
NO CHANGE
Target $117
HCWC
Buy
Mirati Therapeutics price target raised to $117 from $84 at H.C. Wainwright
H.C. Wainwright analyst Edward White raised his price target for Mirati Therapeutics (MRTX) to $117 from $84 saying the positive data for Amgen's (AMGN) AMG 510 bode well for Mirati's MRTX849. The analyst believes the AMG 510 data "somewhat derisks" the development of MRTX849/ He raised his estimate for probability of success for MRTX849 to 20% from 10% and keeps a Buy rating on Mirati Therapeutics.
06/05/19
LEHM
06/05/19
NO CHANGE
Target $123
LEHM
Overweight
Mirati Therapeutics price target raised to $123 from $85 at Barclays
Barclays analyst Gena Wang raised her price target for Mirati Therapeutics (MRTX) to $123 from $85 saying Amgen's (AMGN) AMG510 data support KRAS G12C as a validated target, and the "impressive" data provide proof of concept for potentially single agent activity in non-small cell lung cancer. The analyst continues to believe that Mirati's MRTX849 could have a more favorable profile based on the preclinical results, including "longer half-life and good tissue penetration." She reiterates an Overweight rating on Mirati Therapeutics.
06/04/19
RHCO
06/04/19
NO CHANGE
Target $120
RHCO
Buy
Mirati Therapeutics price target raised to $120 from $85 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Mirati Therapeutics (MRTX) to $120 and kept his Buy rating following yesterday's "encouraging" ASCO presentation by Amgen (AMGN) regarding its KRAS G12C inhibitor AMG 510. The analyst notes that the side effect profile and response to the treatment's lowest dose in AMG 510 are positive for Mirati's MRTX849, raising his probability Adjusted Peak Sales for the latter to $1.65B from $1.33B with probability of success little changed at 52%.

TODAY'S FREE FLY STORIES

11:07
07/16/19
07/16
11:07
07/16/19
11:07
General news
8-Week Bill Announcement Offering Amount data reported »

8-Week Bill Announcement…

11:07
07/16/19
07/16
11:07
07/16/19
11:07
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

SKX

Skechers

$34.40

0.16 (0.47%)

11:05
07/16/19
07/16
11:05
07/16/19
11:05
Options
Skechers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

YMAB

Y-mAbs Therapeutics

$22.80

-0.19 (-0.83%)

11:03
07/16/19
07/16
11:03
07/16/19
11:03
Conference/Events
Y-mAbs Therapeutics management to meet with Cowen »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 09

    Sep

SABR

Sabre

$23.20

0.015 (0.06%)

11:02
07/16/19
07/16
11:02
07/16/19
11:02
Hot Stocks
Sabre, ARC sign agreement to streamline travel agencies' NDC transition »

Airlines Reporting Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$46.00

-0.7 (-1.50%)

10:57
07/16/19
07/16
10:57
07/16/19
10:57
Hot Stocks
Wells Fargo interim CEO says no development to report with DOJ, SEC probes »

Wells Fargo interim CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

MOMO

Momo

$33.77

-0.62 (-1.80%)

10:55
07/16/19
07/16
10:55
07/16/19
10:55
Options
Momo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:55
07/16/19
07/16
10:55
07/16/19
10:55
General news
Today's U.S. reports »

Today's U.S. reports…

ATRA

Atara Biotherapeutics

10:51
07/16/19
07/16
10:51
07/16/19
10:51
Recommendations
Atara Biotherapeutics analyst commentary at Roth Capital »

Atara delayed timing of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNO

Vornado

$65.42

-0.06 (-0.09%)

10:49
07/16/19
07/16
10:49
07/16/19
10:49
Hot Stocks
Vornado sees 5c decrease in Q2 FFO due to certain items »

Vornado Realty Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 07

    Aug

CCJ

Cameco

$10.24

0.03 (0.29%)

10:45
07/16/19
07/16
10:45
07/16/19
10:45
Options
Cameco call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
07/16/19
07/16
10:45
07/16/19
10:45
General news
Breaking General news story  »

8-Week Bill Announcement…

10:45
07/16/19
07/16
10:45
07/16/19
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

WFC

Wells Fargo

$46.25

-0.45 (-0.96%)

10:41
07/16/19
07/16
10:41
07/16/19
10:41
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo sees FY19,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

SNE

Sony

$54.33

-1.44 (-2.58%)

10:35
07/16/19
07/16
10:35
07/16/19
10:35
Options
Sony put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

WFC

Wells Fargo

$46.55

-0.15 (-0.32%)

10:33
07/16/19
07/16
10:33
07/16/19
10:33
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo CFO says 38…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

GCAP

Gain Capital

$4.54

0.51 (12.66%)

10:29
07/16/19
07/16
10:29
07/16/19
10:29
Hot Stocks
Gain Capital up 50c, or 12%, to $4.53 in early trading »

Contacts have indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

WFC

Wells Fargo

$46.88

0.18 (0.39%)

10:27
07/16/19
07/16
10:27
07/16/19
10:27
Hot Stocks
Breaking Hot Stocks news story on Wells Fargo »

Wells Fargo sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

WFC

Wells Fargo

$46.88

0.18 (0.39%)

10:26
07/16/19
07/16
10:26
07/16/19
10:26
Hot Stocks
Wells Fargo sees FY19 NII down near 5% »

Management says auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 12

    Oct

KMX

CarMax

$84.47

-4.31 (-4.85%)

10:25
07/16/19
07/16
10:25
07/16/19
10:25
Options
CarMax call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

EGHT

8x8, Inc.

$25.38

-0.24 (-0.94%)

, FIVN

Five9

$50.13

2.13 (4.44%)

10:25
07/16/19
07/16
10:25
07/16/19
10:25
Conference/Events
Stephens communications analysts to hold an analyst/industry conference call »

Communications Analysts,…

EGHT

8x8, Inc.

$25.38

-0.24 (-0.94%)

FIVN

Five9

$50.13

2.13 (4.44%)

LOGM

LogMeln

$76.20

-0.37 (-0.48%)

RNG

RingCentral

$124.44

1.13 (0.92%)

WORK

Slack Technologies

$34.84

0.06 (0.17%)

TWLO

Twilio

$147.01

1.655 (1.14%)

VG

Vonage

$12.82

0.03 (0.23%)

ZM

Zoom Video

$98.50

-1.26 (-1.26%)

GOOG

Alphabet

$1,150.69

0.3 (0.03%)

MSFT

Microsoft

$138.20

-0.74 (-0.53%)

AMZN

Amazon.com

$2,019.00

-2 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 25

    Jul

  • 25

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Oct

  • 13

    Nov

UBER

Uber

$44.49

-0.02 (-0.04%)

, LYFT

Lyft

$64.80

(0.00%)

10:22
07/16/19
07/16
10:22
07/16/19
10:22
Periodicals
Court says NYC can ban ads inside Uber, Lyft vehicles, Reuters reports »

Reversing a lower court…

UBER

Uber

$44.49

-0.02 (-0.04%)

LYFT

Lyft

$64.80

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 08

    Aug

  • 08

    Aug

FCAU

Fiat Chrysler

$13.61

-0.565 (-3.99%)

, WORK

Slack Technologies

$34.75

-0.03 (-0.09%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Initiation
Fly Intel: Top five analyst initiations »

Catch up on today's…

FCAU

Fiat Chrysler

$13.61

-0.565 (-3.99%)

WORK

Slack Technologies

$34.75

-0.03 (-0.09%)

BTE

Baytex Energy

$1.47

0.03 (2.08%)

TOWN

TowneBank

$26.85

(0.00%)

VET

Vermilion Energy

$21.76

-0.2 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 29

    Jul

  • 31

    Jul

  • 11

    Sep

HD

Home Depot

$218.16

-0.55 (-0.25%)

, SON

Sonoco

$64.48

-0.005 (-0.01%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Downgrade
Fly Intel: Top five analyst downgrades »

Catch up on today's…

HD

Home Depot

$218.16

-0.55 (-0.25%)

SON

Sonoco

$64.48

-0.005 (-0.01%)

PH

Parker-Hannifin

$172.01

4.33 (2.58%)

FDS

FactSet

$281.22

-13.02 (-4.43%)

KMT

Kennametal

$35.09

0.295 (0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 01

    Aug

  • 06

    Aug

  • 12

    Aug

  • 20

    Aug

  • 20

    Aug

  • 17

    Oct

LH

LabCorp

$174.70

0.155 (0.09%)

, TKR

Timken

$48.61

0.92 (1.93%)

10:20
07/16/19
07/16
10:20
07/16/19
10:20
Upgrade
Fly Intel: Top five analyst upgrades »

Catch up on today's…

LH

LabCorp

$174.70

0.155 (0.09%)

TKR

Timken

$48.61

0.92 (1.93%)

FCX

Freeport McMoRan

$11.23

0.09 (0.81%)

WPM

Wheaton Precious Metals

$24.45

0.27 (1.12%)

OMF

OneMain Holdings

$35.07

1.135 (3.34%)

NOK

Nokia

$5.15

0.045 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 06

    Aug

  • 09

    Aug

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.